C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/575 (2006.01)
Patent
CA 2617649
The present invention relates generally to novel, selectable hybrid polypeptides useful as agents for the treatment and prevention of metabolic diseases and disorders which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, such as diabetes and diabetes-related conditions. Such conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, including type 1, type 2, and gestational diabetes.
L'invention concerne généralement de nouveaux polypeptides hybrides sélectionnables servant d'agents pour le traitement et pour la prévention de maladies et de troubles métaboliques pouvant être soulagés par le contrôle des taux de glucose dans le plasma, des taux d'insuline, et/ou de la sécrétion d'insuline, notamment les diabètes et les troubles associés à ces diabètes. De tels troubles et de tels états pathologiques comprennent, de manière non exhaustive, l'hypertension, la dyslipidémie, les maladies cardio-vasculaires, les troubles alimentaires, la résistance à l'insuline, l'obésité et le diabète sucré, et tous les types de diabètes gestationnels, ainsi que les diabètes de type 1 et de type 2.
D'souza Lawrence J.
Forood Behrouz Bruce
Ghosh Soumitra S.
Hanley Michael R.
Jodka Carolyn M.
Amylin Pharmaceuticals Inc.
Smart & Biggar
LandOfFree
Hybrid polypeptides with selectable properties does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybrid polypeptides with selectable properties, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid polypeptides with selectable properties will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1754390